As of 2025-12-19, the Intrinsic Value of Rapt Therapeutics Inc (RAPT) is -19.06 USD. This RAPT valuation is based on the model Peter Lynch Fair Value. With the current market price of 34.04 USD, the upside of Rapt Therapeutics Inc is -156.00%.
Based on its market price of 34.04 USD and our intrinsic valuation, Rapt Therapeutics Inc (RAPT) is overvalued by 156.00%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -19.06 - -19.06 | -19.06 | -156.00% |
| P/E | (28.82) - (54.06) | (39.84) | -217.0% |
| DDM - Stable | (19.74) - (55.16) | (37.45) | -210.0% |
| DDM - Multi | (2.88) - (6.34) | (3.96) | -111.6% |
| Market Cap (mil) | 943.25 |
| Beta | 1.68 |
| Outstanding shares (mil) | 27.71 |
| Enterprise Value (mil) | 905.32 |
| Market risk premium | 4.60% |
| Cost of Equity | 13.87% |
| Cost of Debt | 5.00% |
| WACC | 8.77% |